Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Adrenal Cancer

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Adrenal Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bosia, A; Braquet, P; Bussolino, F; Camussi, G; Prosdocimi, M; Tessari, F; Turrini, F1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Adrenal Cancer

ArticleYear
Platelet activating factor induces dopamine release in PC-12 cell line.
    The American journal of physiology, 1988, Volume: 255, Issue:4 Pt 1

    Topics: Adrenal Gland Neoplasms; Animals; Atropine; Calcium; Carbachol; Cell Line; Diterpenes; Dopamine; Ginkgolides; Kinetics; Lactones; Pheochromocytoma; Phospholipid Ethers; Platelet Activating Factor

1988